Evolving Cannabinoid Drug Development: Next Generation Multi-Target Therapeutics

Time: 4:00 pm
day: Day Two

Details:

  • Exploring a complex therapeutic mixture including cannabinoids, terpenes, and other flavonoids to target the neuro-degenerative effects of CNS disorders such as ALS
  • Using innovative technologies to identify and extract the required rare polyphenols at high-potencies
  • Utilizing artificial intelligence to help screen the cannabis plant for enhanced insight into which components to research

Speakers: